VIDEO: Dr. Timothy Vollmer

 

Dr. Timothy Vollmer

"There have been significant advances in the last few years about the cause of MS 
There appears to be several different factors. One is genetics; the disease is more prevalent in people from Northern Europe. The second one is low Vitamin D levels early in life, and possibly in in-utero, increase the risk of MS subsequently," University of Colorado Doctor Tim Vollmer said.

He says people in Colorado are normally diagnosed with low-levels of Vitamin D. Some experts believe Vitamin D levels may be low in the state because of Coloradan's use of sunscreen.

Vollmer says new MS research and treatments are progressing at a remarkable rate.

"The field Multiple Sclerosis is one of the most rapidly evolving fields of medicine right now. We have eight FDA therapies and three that are likely to be approved within the next year to 18 months. In the last year or so, we've developed a new blood test that would identify patients who are at risk of some of the serious side effects of the drugs. As a consequence, we can now identify people who are likely to do very well on a certain drug with a very low risk," Vollmer said.
Read more »

Labels: 100 MOST POPULAR, Dr. Timothy Vollmer, Tecfidera, Tysabri, Video

IMPORTANT: On August 31st we posted breaking news about the Gilenya-PML Problem along with our News Editor Beth Perkins's video that is below! Our Publisher Stan Swartz immediately called both Dr. Timothy Vollmer & Dr. Brian Apatoff and asked each of them to give advice about what our MSnewsChannel.com viewers who are on Gilenya should do. We immediately posted both Dr. Vollmer's & Dr. Apatoff's advice. DR VOLLMER WILL BE GIVING US HIS UPDATED ADVICE ON THE GILENYA-PML PROBLEM AFTER HE ATTENDS A MEETING OF NEUROLOGISTS IN COPENHAGEN THE END OF THIS MONTH (READ DR. VOLLMER'S EMAIL BELOW) WE WILL EMAIL DR. VOLLMER'S UPDATED-OPINION DIRECTLY TO YOUR EMAIL IN-BOX! SO CLICK ON THE LINK BELOW TO GET YOUR FREE DRUG-ALERT FROM DR. VOLLMER! WE WILL ALSO BE EMAILING FUTURE OPINIONS ON MS DRUG PROBLEMS FROM BOTH DR. VOLLMER AND DR. APATOFF

CLICK TO GET DR VOLLMERS'S UPDATE ON THE GILENYA-PML PROBLEM PLUS ANY PROBLEMS ON ALL OF THE OTHER MS TREATMENTS IN THE FUTURE!

WE POSTED EVERYTHING BELOW THIS SENTENCE LAST WEEK WITHIN A FEW HOURS OF THE BREAKING NEWS ABOUT THE GILENYA-PLM PROBLEM:

I'M BETH! Watch my 1 minute video on the GILENYA & PML

BREAKING NEWS: FDA Warns of PML Case With Gilenya 

"The FDA advised clinicians to report side effects involving fingolimod to its adverse-event reporting system. It also told patients currently taking the drug not to stop it without talking first with their physicians"

MEDSCAPE: A patient being treated for multiple sclerosis and who had no history of using natalizumab (Tysabri) developed progressive multifocal leukoencephalopathy (PML) while taking fingolimod (Gilenya), the FDA said. 

READ DR. VOLLMER'S & DR. APATOFF'S ADVICE ON THE GILENYA-PML PROBLEM BY CLICKING ON THE PURPLE Read More BELOW:

Read more »

Labels: 500 Best PML Stories & Studies, Dr. Timothy Vollmer, PML (Progressive Multifocal Leukoencephalopathy)